Phase IV, open, low-level intervention, clinical trial to compare the immunogenicity in immunosuppressed patients of an adjuvanted anti-hepatitis B vaccine with an anti-hepatitis B vaccine with increased antigenic load
Latest Information Update: 18 Mar 2024
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary) ; Hepatitis B vaccine recombinant (HBvaxPro) (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 15 Mar 2024 Status changed from recruiting to completed.
- 07 Aug 2018 New trial record